ProfileGDS4718 / 227803_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 6% 22% 11% 22% 31% 45% 31% 24% 25% 15% 24% 31% 39% 45% 25% 46% 49% 66% 62% 25% 12% 25% 37% 30% 22% 46% 33% 46% 28% 34% 59% 46% 16% 29% 58% 55% 38% 28% 26% 6% 36% 62% 46% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.651926
GSM549102patient 115, normal, homogenized [OPG study]4.2243122
GSM549104patient 119, normal, homogenized [OPG study]3.8021811
GSM549108patient 138, normal, homogenized [OPG study]4.2462622
GSM549119patient 077, normal, homogenized [OPG study]4.5861131
GSM549133patient 032, cancer, homogenized [OPG study]5.1754145
GSM549139patient 042, cancer, homogenized [OPG study]4.5653631
GSM549099patient 107, normal, homogenized [OPG study]4.3029524
GSM549109patient 139, normal, homogenized [OPG study]4.3781625
GSM549110patient 046, normal, homogenized [OPG study]3.9716215
GSM549114patient 063, normal, homogenized [OPG study]4.2640424
GSM549122patient 082, normal, homogenized [OPG study]4.5997531
GSM549134patient 033, cancer, homogenized [OPG study]4.9151639
GSM549136patient 036, cancer, homogenized [OPG study]5.1622845
GSM549140patient 044, cancer, homogenized [OPG study]4.2953325
GSM549111patient 047, normal, homogenized [OPG study]5.2930746
GSM549113patient 057, normal, homogenized [OPG study]5.4053349
GSM549132patient 031, cancer, homogenized [OPG study]6.5556666
GSM549137patient 038, cancer, homogenized [OPG study]6.3014462
GSM549142patient 047, cancer, homogenized [OPG study]4.4324225
GSM549100patient 110, normal, homogenized [OPG study]3.8576512
GSM549107patient 135, normal, homogenized [OPG study]4.3022725
GSM549115patient 068, normal, homogenized [OPG study]4.7794737
GSM549116patient 072, normal, homogenized [OPG study]4.5080830
GSM549120patient 078, normal, homogenized [OPG study]4.2246222
GSM549131patient 030, cancer, homogenized [OPG study]5.2417546
GSM549118patient 074, normal, homogenized [OPG study]4.6788233
GSM549129patient 027, cancer, homogenized [OPG study]5.3139646
GSM549123patient 088, normal, homogenized [OPG study]4.4355428
GSM549124patient 006, cancer, homogenized [OPG study]4.7736934
GSM549126patient 015, cancer, homogenized [OPG study]6.0167259
GSM549128patient 025, cancer, homogenized [OPG study]5.298646
GSM549103patient 117, normal, homogenized [OPG study]4.0275216
GSM549117patient 073, normal, homogenized [OPG study]4.4610929
GSM549138patient 041, cancer, homogenized [OPG study]6.0114958
GSM549141patient 045, cancer, homogenized [OPG study]5.8037155
GSM549130patient 028, cancer, homogenized [OPG study]4.9132138
GSM549101patient 111, normal, homogenized [OPG study]4.4779728
GSM549105patient 128, normal, homogenized [OPG study]4.3872626
GSM549106patient 134, normal, homogenized [OPG study]3.589136
GSM549112patient 048, normal, homogenized [OPG study]4.7835736
GSM549125patient 011, cancer, homogenized [OPG study]6.2645862
GSM549127patient 024, cancer, homogenized [OPG study]5.3175646
GSM549135patient 035, cancer, homogenized [OPG study]6.5278665